From GlobeNewswire: 2025-02-20 11:42:15

HOOKIPA Pharma Inc. will not be making an offer for Poolbeg Pharma plc after non-binding discussions and a PUSU extension. The HOOKIPA Board has decided not to proceed under Rule 2.7 of the Code but reserves the right to reconsider under specific circumstances. The announcement falls under Rule 2.8 of the Code and was released by CEO Malte Peters. Moelis & Company is the financial adviser to HOOKIPA in this potential combination. The full statement can be found on HOOKIPA’s website for further details. This announcement does not constitute an offer or solicitation for any securities in any jurisdiction.



Read more at GlobeNewswire: HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding